Law M - Search Results

1

High hepatitis C treatment uptake among people with recent drug dependence in New South Wales, Australia.

Valerio H, Alavi M, Law M, Tillakeratne S, Amin J, Janjua NZ, Krajden M, George J, Matthews GV, Hajarizadeh B, Degenhardt L, Grebely J, Dore GJ. Valerio H, et al. Among authors: law m. J Hepatol. 2021 Feb;74(2):293-302. doi: 10.1016/j.jhep.2020.08.038. Epub 2020 Sep 12. J Hepatol. 2021. PMID: 32931879

2

Is severe liver disease a common outcome for people with chronic hepatitis C?

Dore GJ, Freeman AJ, Law M, Kaldor JM. Dore GJ, et al. Among authors: law m. J Gastroenterol Hepatol. 2002 Apr;17(4):423-30. doi: 10.1046/j.1440-1746.2002.02730.x. J Gastroenterol Hepatol. 2002. PMID: 11982723 Review.

3

A randomized, double-blind study of gemfibrozil for the treatment of protease inhibitor-associated hypertriglyceridaemia.

Miller J, Brown D, Amin J, Kent-Hughes J, Law M, Kaldor J, Cooper DA, Carr A. Miller J, et al. Among authors: law m. AIDS. 2002 Nov 8;16(16):2195-200. doi: 10.1097/00002030-200211080-00012. AIDS. 2002. PMID: 12409741 Clinical Trial.

4

Epidemiology of hepatitis C virus infection in Australia.

Dore GJ, Law M, MacDonald M, Kaldor JM. Dore GJ, et al. Among authors: law m. J Clin Virol. 2003 Feb;26(2):171-84. doi: 10.1016/s1386-6532(02)00116-6. J Clin Virol. 2003. PMID: 12600649 Review.

5

The impact of behavioural changes on the prevalence of human immunodeficiency virus and hepatitis C among injecting drug users.

Murray JM, Law MG, Gao Z, Kaldor JM. Murray JM, et al. Among authors: law mg. Int J Epidemiol. 2003 Oct;32(5):708-14. doi: 10.1093/ije/dyg102. Int J Epidemiol. 2003. PMID: 14559736

6

Modelling hepatitis C virus incidence, prevalence and long-term sequelae in Australia, 2001.

Law MG, Dore GJ, Bath N, Thompson S, Crofts N, Dolan K, Giles W, Gow P, Kaldor J, Loveday S, Powell E, Spencer J, Wodak A. Law MG, et al. Int J Epidemiol. 2003 Oct;32(5):717-24. doi: 10.1093/ije/dyg101. Int J Epidemiol. 2003. PMID: 14559738

7

Epidemiology of hepatitis C virus infection in Australia.

Dore GJ, MacDonald M, Law MG, Kaldor JM. Dore GJ, et al. Among authors: law mg. Aust Fam Physician. 2003 Oct;32(10):796-8. Aust Fam Physician. 2003. PMID: 14596073 No abstract available.

8

Natural history models for hepatitis C-related liver disease: different disease progression parameters for different settings.

Dore GJ, Freeman AJ, Law M, Kaldor JM. Dore GJ, et al. Among authors: law m. Antivir Ther. 2003 Oct;8(5):365-72. Antivir Ther. 2003. PMID: 14640382 Review.

9

Changes in hematologic parameters and efficacy of thymidine analogue-based, highly active antiretroviral therapy: a meta-analysis of six prospective, randomized, comparative studies.

Moyle G, Sawyer W, Law M, Amin J, Hill A. Moyle G, et al. Among authors: law m. Clin Ther. 2004 Jan;26(1):92-7. doi: 10.1016/s0149-2918(04)90009-4. Clin Ther. 2004. PMID: 14996521

10

HIV disease progression in a patient cohort treated via a clinical research network in a resource limited setting.

Duncombe C, Kerr SJ, Ruxrungtham K, Dore GJ, Law MG, Emery S, Lange JM, Phanuphak P, Cooper DA. Duncombe C, et al. Among authors: law mg. AIDS. 2005 Jan 28;19(2):169-78. doi: 10.1097/00002030-200501280-00009. AIDS. 2005. PMID: 15668542

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

2,695 results

Search Page

Filters